Washington Trust Advisors, Inc. Dexcom Inc Transaction History

Washington Trust Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$75.49 - $124.16 $14,569 - $23,962	193 Added 120.63%	353 $43,000
Q3 2023 Oct 18, 2023	BUY	$86.06 - $137.93 $13,769 - $22,068	160 New	160 $14,000
Q1 2023 May 04, 2023	SELL	$104.0 - $122.92 $2,496 - $2,950	-24 Reduced 10.53%	204 $23,000
Q2 2022 Jul 25, 2022	BUY	$67.99 - $132.89 $12,442 - $24,318	183 Added 406.67%	228 $17,000
Q1 2022 May 05, 2022	SELL	$94.08 - $130.2 $12,136 - $16,795	-129 Reduced 74.14%	45 $23,000
Q4 2021 Feb 11, 2022	BUY	$129.87 - $162.82 $22,597 - $28,330	174 New	174 $93,000

1,035

353M

5.51M

5.61M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Washington Trust Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Washington Trust Advisors, Inc. with notifications on news.